A network of experts in reproductive and children’s environmental health

Indoor Environmental Health > Carbon Monoxide Exposure in Pediatric and Pregnant Populations

Carbon Monoxide Exposure in Pediatric and Pregnant Populations

posted on Apr 30, 2019
This course qualifies as continuing education for physicians, nurses, certified health education specialists, certified public health professionals and other professionals provided by the Centers for Disease Control and its partners. 

CE Origination Date – 01/07/2019
CE Expiration Date – 01/07/2021

The goal of this activity is to enhance the knowledge of physicians and other healthcare providers about the effects of carbon monoxide exposure in pediatric and pregnant populations.

Learning Objectives

  1. Describe one method on how carbon monoxide is formed.
  2. Describe the four phases of how carbon monoxide is processed within the body.
  3. Explain at least two pathophysiological effects of carbon monoxide within the body.
  4. Identify three clinical manifestations of carbon monoxide exposure.
  5. Identify one recommend treatment method for pediatric or pregnant patients exposed to carbon monoxide.

Developed By

Jennifer Lowry, MD, FACMTLowry_Photo_Nov2018.jpg
Chief, Section of Clinical Toxicology
Medical Director, Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation
Children's Mercy Kansas City

This material was supported by the American Academy of Pediatrics (AAP) and funded (in part) by the cooperative agreement FAIN: 5 NU61TS000237-05 along with the American College of Medical Toxicology and funded (in part) by the cooperative agreement FAIN: 5U61TS000238-05 from the Agency for Toxic Substances and Disease Registry (ATSDR).

Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications.